Healthcare Regulations and Pricing Pressures: Changes in government healthcare policies, drug approval processes, and pricing regulations directly impact J&J's pharmaceutical and medical device segments, leading to compliance costs and potential legal actions.

Rising Healthcare Costs and Workforce Shortages: The healthcare industry is facing increasing costs and persistent workforce shortages, impacting operations and requiring companies like J&J to adapt to new cost structures and care models.

Technological Advancements and AI Integration: The expanding role of technology, particularly artificial intelligence, is reshaping drug development, diagnostics, and patient care, presenting both opportunities for innovation and competitive pressures.